Výsledky vyhledávání

Akademický článek

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire

Autor: L. C. Coates, A.-M. Orbai, V. F. Azevedo, J. C. Cappelleri, K. Steinberg, R. Lippe, I. Lim, L. Eder, P. Richette, M. Y. Weng, R. Queiro Silva, L. Fallon

Publikováno v: Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020)

Abstract Background Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory musculoskeletal disease, manifesting as peripheral arthritis, enthesitis, dactylitis, spondylitis, and skin and nail psoriasis. A core set of domains for measurin

Externí odkaz: https://doaj.org/article/aa0cb69614bc48d696e133196bea7757

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POS1016 RELATIONSHIPS BETWEEN DISEASE DURATION AND RADIOGRAPHIC PROGRESSION AMONG PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB IN FUTURE 5

Autor: C. T. Ritchlin, A. M. Orbai, B. Parikh, C. Gaillez, X. Meng, P. J. Mease

Publikováno v: Annals of the Rheumatic Diseases. 81:817-818

BackgroundFor patients with psoriatic arthritis (PsA), delays in diagnosis and treatment can lead to permanent radiographic damage, even early in the course of disease.1 In the phase 3 FUTURE 5 study (NCT02404350), treatment with secukinumab (SEC) wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f64420201c0091b7667d4f1242d8087
https://doi.org/10.1136/annrheumdis-2022-eular.278

Zobrazit plný text záznamu

POS1076 OBESITY IS ASSOCIATED WITH LESS LIKELIHOOD OF REMISSION/ LOW DISEASE IN PSORIATIC ARTHRITIS, A CROSS-SECTIONAL STUDY OF 414 PATIENTS

Autor: Y. Y. Leung, L. Eder, A. M. Orbai, L. Coates, M. De Wit, J. S. Smolen, U. Kiltz, P. Palominos, J. D. D. Cañete, R. Scrivo, A. Balanescu, E. Dernis, S. Meisalu, M. Soubrier, U. Kalyoncu, L. Gossec

Publikováno v: Annals of the Rheumatic Diseases. 81:863.1-863

BackgroundObesity is a risk factor for psoriatic arthritis (PsA) and is associated with higher disease activity [1].ObjectivesWe aimed to evaluate whether obese patients with PsA were less likely to achieve remission/low disease in a real-life multi-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19ae0eb2132a98309cf6844d85371490
https://doi.org/10.1136/annrheumdis-2022-eular.2099

Zobrazit plný text záznamu

POS1066 DEVELOPMENT OF PHYSICAL AND MENTAL COMPONENT SUMMARY SCORES FROM PROMIS-29 INSTRUMENT IN PATIENTS WITH PSORIATIC ARTHRITIS

Autor: L. Coates, A. M. Orbai, A. Deodhar, A. Kollmeier, M. Shawi, Y. H. Liu, Y. Liu, C. Han

Publikováno v: Annals of the Rheumatic Diseases. 81:855.2-856

BackgroundPatients (pts) with psoriatic arthritis (PsA) experience pain, fatigue, anxiety, depression, sleep disturbance, and impaired physical function that can negatively affect health-related quality of life (HRQoL).1 As the Patient-Reported Outco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50180b5f0159f9d9447f8c3e35b7577a
https://doi.org/10.1136/annrheumdis-2022-eular.885

Zobrazit plný text záznamu

POS1022 RELATIONSHIPS BETWEEN INHIBITION OF RADIOGRAPHIC PROGRESSION AND ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION AND THEIR CORE COMPONENTS IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB IN FUTURE 5 DURING THE FIRST 24 WEEKS

Autor: P. J. Mease, A. M. Orbai, B. Parikh, C. Gaillez, X. Meng, C. T. Ritchlin

Publikováno v: Annals of the Rheumatic Diseases. 81:822-822

BackgroundPatients with active psoriatic arthritis (PsA) experience inflammation that may result in structural damage and disability. In the phase 3 FUTURE 5 study, treatment with secukinumab (SEC) inhibited radiographic progression and led to sustai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2c2026186cf6fa43c9dcb51c628af2c
https://doi.org/10.1136/annrheumdis-2022-eular.1167

Zobrazit plný text záznamu

POS0004 WHAT DOES WORSENING IN DAPSA DISEASE ACTIVITY CATEGORIES MEAN FOR PATIENTS WITH PSORIATIC ARTHRITIS? AN ANALYSIS OF 222 PATIENTS

Publikováno v: Annals of the Rheumatic Diseases. 81:214.1-215

BackgroundIn psoriatic arthritis (PsA), disease activity states have been defined using the DAPSA (Disease Activity index for Psoriatic Arthritis) score (1). The disease activity states have been validated using structural progression as the gold sta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fae626e189f9f65c233593e1820e6508
https://doi.org/10.1136/annrheumdis-2022-eular.1493

Zobrazit plný text záznamu

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire

Autor: R. Lippe, I. Lim, Karyn Meltz Steinberg, Pascal Richette, Lara Fallon, Valderilio Azevedo, R. Queiro Silva, Meng Yu Weng, Joseph C. Cappelleri, A. M. Orbai, Laura C. Coates, Lihi Eder

Publikováno v: Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020)

Background Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory musculoskeletal disease, manifesting as peripheral arthritis, enthesitis, dactylitis, spondylitis, and skin and nail psoriasis. A core set of domains for measuring the imp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aada5ec2b0aee233358b504420623e20
https://doi.org/10.1186/s12955-020-01422-z

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání